Ignite Creation Date:
2024-07-17 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06485713
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-04-11
Brief Title:
Efficacy and Safety of TrifluridineTipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC
Sponsor:
First Affiliated Hospital of Wenzhou Medical University
Organization:
First Affiliated Hospital of Wenzhou Medical University
Study Overview
Official Title:
Efficacy and Safety of TrifluridineTipiracil Combined With Fufuquitinib Versus TrifluridineTipiracil and Fufuquitinib for Third-line Treatment of Unresectable Metastatic Colorectal Cancer
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the efficacy and safety of trifluridinetipiracil combined with fufuquitinib versus trifluridinetipiracil and fufuquitinib in patients with unresectable metastatic colorectal cancer
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None